PD-L1-Targeted Lutetium-177 Radiotherapy Shrinks Triple-Negative Breast Tumors in Mice
Radiolabeled atezolizumab with lutetium-177 significantly reduced tumor volumes and extended median survival in a mouse model of triple-negative breast cancer.
Tag: EJNMMI Research
Kidney Radiation Doses Stay Low in Most Men After PSMA Therapy
A retrospective analysis of 127 patients found that only 5 percent-level few exceeded 20 Gy cumulative kidney dose after lutetium-177 ...
POPULAR NEWS
-
Adolescents With Self-Injury Linger Longer on NSSI-Related Social Media Posts, Eye-Tracking Study Finds
-
Multi-omics study links autophagy and ER stress to PFOA toxicity in sperm precursor cells
-
Single-center cohort maps real-world treatment sequencing in ovarian carcinosarcoma
-
Ancient Chinese Formula Sini Decoction Rewires Immune Cells in Lab Study of Atherosclerosis